Amyloidosis; Systemic
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis (NCT05201911) | Attralus, Inc. | 2021-11-30 |
| Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis (NCT04474938) | Peking Union Medical College Hospital | 2021-05-24 |
| BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients (NCT03401372) | Jian Li | 2018-04-21 |
| Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients (NCT02994784) | Boston Medical Center | 2018-01-08 |
Track Amyloidosis; Systemic automatically
Every clearance here is in the API, with alerts when new ones post.